Sign in

CIK 0000879407 · Large accelerated filer

ARROWHEAD PHARMACEUTICALS, INC.

Sign in to watch
Ticker
ARWR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
DE
Entity type
operating
EIN
460408024
Phone
626-696-4702
Business address
177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
Former names
ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,186,600
in 2 filings

Net −$1,186,600. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. PERRY MICHAEL S −$1.0M Director sold 9% of stake
  2. OLUKOTUN ADEOYE Y −$174K Director sold 6% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-01-10 Ferrari Mauro Director Grant or award · Common Stock +4,593 4,593
2023-01-10 De Backer Marianne Director Grant or award +7,867 31,267
2023-01-10 De Backer Marianne Director Grant or award · Common Stock +4,593 4,593
2023-01-10 Vakiener Victoria Director Returned to the company −1,764 15,417
2023-01-10 Vakiener Victoria Director Grant or award +7,867 23,284
2023-01-10 Vakiener Victoria Director Grant or award · Common Stock +4,593 4,593
2023-01-10 PERRY MICHAEL S Director Grant or award +7,867 99,767
2023-01-10 PERRY MICHAEL S Director Grant or award · Common Stock +4,593 4,593
2023-01-10 GIVEN DOUGLAS B Director Grant or award +7,867 124,135
2023-01-10 GIVEN DOUGLAS B Director Grant or award · Common Stock +4,593 4,593
2023-01-10 Waddill William D. Director Grant or award +7,867 36,817
2023-01-10 Waddill William D. Director Grant or award · Common Stock +4,593 4,593
2023-01-10 OLUKOTUN ADEOYE Y Director Grant or award +7,867 19,217
2023-01-10 OLUKOTUN ADEOYE Y Director Grant or award · Common Stock +4,593 4,593
2023-01-09 Waddill William D. Director Sale −3,200 $30.00 $96K 28,950
2023-01-05 O'Brien Patrick COO and General Counsel Sale −7,500 $37.39 $280K 420,875
2023-01-05 O'Brien Patrick COO and General Counsel Sale −7,500 $37.39 $280K 413,375
2023-01-05 Hamilton James C Chief Discovery/Trans Medicine Sale −7,230 $37.40 $270K 198,057
2023-01-05 Hamilton James C Chief Discovery/Trans Medicine Sale −6,573 $37.40 $246K 191,484
2023-01-04 Oliver Tracie Chief Commercial Officer Grant or award +500 70,500

Page 12 of 38 · 752 trades